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Biotechnology is a huge field. This discussion will be limited to processes which 
require the manipulation of genetic material to produce a substance which is 
administered to a farm animal or manipulation of the animal's own genetic material. 
This paper is not intended to be a comprehensive review of all animal related 
biotechnology research but rather a brief outline of both the detrimental and positive 
effects of biotechnology on animal welfare. In the last section of the paper ethical 
questions will be discussed from the viewpoint of the author who has had years of 
experience in making practical improvements in animal handling and slaughter 
practices.1•2 
The use of biotechnology with farm animals can be divided into seven basic 
categories. The first category is the use of substances produced by biotechnology 
methods to improve the productivity of farm animals. One example is growth hormone 
injections. The second category is transgenic animals where a gene from another species 
is incorporated into an animal. An example is the insertion of human growth hormone 
genes into pigs. The third category is transgenic animals used as animal models in 
biomedical research and the fourth category is creating mosaic animals which are 
combinations of two species which normally do not interbreed. The fifth use of 
biotechnology is inserting genes into animals which will enable them to make medically 
valuable substances in their milk. The sixth area is deleting or adding genes to study 
basic principles of gene expression or replacing faulty genes to correct a genetic defect. 
The last category is an indirect use of biotechnology. Examples would be diagnostic tests 
and DNA fingerprinting. 
GROWTH HORMONE AND VACCINES 
Early experiments with porcine growth hormone indicated that high doses had 
very detrimental effects on the welfare of pigs. Very high doses of 10.34 mg to 54.7 mg 
per day resulted in liver and kidney degeneration, edema and arthritis.1 A lower dose 
of 6.11 mg per day had no ill effects. L. J. Machlin concluded that pigs were much more 
sensitive to the detrimental effects of high doses of growth hormone compared to rats.3 
A review of all the abstracts in the growth and development section of the 1990 
book of abstracts published by the American Society of Animal Science indicated that 
doses under 6.11 mg per day were used in most of the studies reported at this year 's 
meeting of the society.4 The use of porcine growth hormone (PST) in moderate doses 
146 
will probably not cause the problems cited by Machlin. In one recent study of Duroc 
and Pietrain pigs, PST and control slaughter weight pigs had no differences in behavior, 
general health, leg problems or carcass abnormalities.5 
In the United States, pigs are often transported long distances from the farm to 
the slaughter plant. After arrival at the slaughter plant the pigs are housed in unheated 
stockyard pens. Stan Curtis, at Pennsylvania State University, calculated that excessive 
leanness may result in cold stress problems during transport. The midwestern U.S. 
becomes very cold during the winter. Temperatures often get down below -17 degrees 
c. 
There are also concerns about pushing animals beyond their physiological limits. 
Some pigs already have leg soundness problems. In the U.S. poultry industry, 2 to 6% 
of all broiler chickens have skeletal problems.6 Elbert Day, professor at Mississippi State 
University, states that sudden death syndrome and skeletal deformities are highly 
associated with rapid growth.3 In both the pork and poultry industries, there are skeletal 
problems occurring without the addition of growth hormone. Some researchers have 
concluded that skeletal deformities and leg weakness "is the price that must be paid for 
rapid growth of broilers. " 5 
There is some evidence that porcine growth hormone will increase bone thickness 
in pigs. Metacarpal thickness and diameter was greater in pigs treated with 3 mg of PST 
per day.7 This may provide stronger bones in mature animals kept for breeding but may 
result in more elastic bones during the growth stages.7 There is a possibility this could 
cause welfare problems for a rapidly growing fattening pig which is marketed prior to 
maturity. In elderly humans growth hormone injections increase lean body mass, 
decrease fat, increase bone density and skin thickness.8 To put it simply, they may 
reverse some of the detrimental effects of aging. Growth hormone is a substance that 
can have both detrimental ancl beneficial effects. It depends on how we use it. 
Bovine growth hormone (BST) will increase milk production in dairy cows. A 
major welfare concern is that already high producing dairy cows will have further 
stressors placed on their physiology. Dairy cows treated with growth hormone require 
a high level of nutrition to prevent a decline in body condition. A University of Maine 
study indicated that dairy cows treated with growth hormone and fed an all forage silage 
diet with no grain had a slight decrease in body condition at the end of a 98-day trial.9 
Injections were started late in lactation on the 186th day. If this trial had been started 
earlier in lactation it is likely that body condition would have further declined. Grain 
supplements may be required to maintain the body condition of dairy cows on BST. 
On a few poorly managed U.S. dairy farms, cows are allowed to decline to a very 
skinny condition. Observations by the author at slaughter plants indicate that about 2% 
of the dairy cows arrive at the plant in a horrible skinny weak condition. The use of 
growth hormone will require better nutrition and a higher level of management expertise 
to prevent an increase of this type of problem. 
Another area of welfare concern is frequent injections. In many studies, pigs 
received a daily injection of growth hormone.4 Other studies have shown that a reduced 
injection schedule of two injections per week is also effective.5 Rough handling or dull 
needles may cause distress to pigs during frequent injections. 
To reduce the need for frequent injections, implants which release the hormone 
slowly are being developed for dairy cows. In some studies these implants are being 
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placed under the skin near the tail head. I am concerned about pain to the cow to 
install the implant every two weeks. It has to be inserted with a thick needle. I am also 
concerned about the implant migrating and getting into hamburger after slaughter. It 
is my opinion that all implants should be placed in the ear. 
Another problem which will have to be addressed if BST and PST become widely 
used is injection site abscesses. In the beef industry, injection site abscesses from 
vaccinations are a serious problem. Rod Bowling of Monfort of Colorado estimates that 
injection site abscesses cost the U.S. beef industry $1.44 per head.10 
Injection site abscesses are also a serious problem in pigs. Pigs will often get 
systemic abscesses which form large pockets of pus far away from the injection site. 
Injections with dirty needles or of substances which are irritating will greatly increase 
abscesses.U The solution to the problem would be the development of ear implants 
which would last many weeks. 
Biotechnology could really improve animal welfare through the development of 
better animal vaccines. Researchers at Texas A&M have genetically altered the 
Brucellosis bacteria so that it no longer causes the disease, but will still provide 
immunity. As research continues, better vaccines against additional animal diseases 
could be developed. Michael Fox, Humane Society of the U.S., warns that products of 
this type may make it possible to stock animals at even greater densities in confinement 
systemsY This would be very detrimental to animal welfare. 
Increased disease resistance in domestic animals could also be detrimental to 
wildlife.13 If a vaccine could be developed for African Sleeping Sickness, cattle could be 
moved into new areas and directly compete with wildlife. The welfare of the cattle may 
be improved, but the welfare of wildlife may be damaged. These two points are 
legitimate concerns, but they are not justification for discontinuing research on better 
vaccines. 
TRANSGENIC FARM ANIMALS 
In 1982, R. D. Palmiter and his colleagues inserted rat growth genes into mice 
and created giant mice.14 In 1983 they achieved the feat of creating giant mice by 
inserting human growth genes.14 The giant mice were normally proportioned and they 
were able to pass the human growth gene on to their offspring.15 The human growth 
gene was heritable in the standard Mendellian manner. In 1985, R. E. Hammer in 
collaboration with R.D. Palmiter accomplished the more difficult task of producing 
transgenic rabbits and pigs which expressed human growth hormone.16 Reseachers at 
the University of Edinburgh have now succeeded in producing transgenic lambs which 
can also pass human genes on to their offspringY 
Transgenic pigs and mice with human growth genes exhibited pathological 
abnormalities and a shorter life span.18 However, the infirmities were much more 
serious in the pigs. Transgenic pigs which expressed human growth hormone were lame, 
lethargic and uncoordinated. They also had ulcers, degenerative joint disease, 
pericarditis, endocarditis, nephritis and pneumonia.18 
The health problems in the transgenic swine were an exaggeration of health 
problems which occur in the regular commercial pig population. V. G. Pursell and his 
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colleagues believe that the infirmities observed in pigs, which express human growth 
hormone, "would have been less frequent and less severe if the genetic .base used in our 
experiments had been selected for structural soundness of legs and the ability to 
withstand commercial rearing conditions. 1118 In transgenic pigs, human growth hormone 
is expressed in many different tissues. Pursell suggests that many of the infirmities are 
caused by a long-term exposure to growth hormone.18 They may just be overdosed all 
over the body. There are still many things that need to be learned about gene 
expression. In the mouse experiments, researchers found that there was a poor 
correlation between gene dosage and the degree of gene expression in the tissues. 
Mice respond to a greater extent to huma11 growth hormone genes compared to 
pigs. Possibly centuries of selection for growth may limit the pigs' response to growth 
hormone.18 Researchers in Edinburgh, England found that chickens selected for rapid 
growth actually make less growth hormoneP 
More recent experiments have also shown a genetic interaction with injected PST 
in normal pigs. Obese lines of pigs had a greater response than a lean line of pigs.19 
Modern pigs are slaughtered at a young age. In older heavier pigs, PST will have a 
greater effect in Pietrains compared to Durocs.Z0 The converse is true at a younger age 
with slaughter weights below 100 kg. 
The use of biotechnology to produce better vaccines was discussed earlier. To 
take the process a step further genes could be introduced into farm animals to produce 
disease resistance.18 An example would be the gene for tick resistance. It could be 
transferred from Zebu to European cattle. 
The most radical transgenic idea is to replace the mitochondria in cattle skin cells 
with chloroplasts. Chloroplasts are the photosynthesis cells of plants. This was predicted 
by Lowell Catlett a futurist at New Mexico State University.21 Chloroplasts would enable 
cattle to eat less food because they could derive a portion of their energy from sunlight. 
This could be detrimental to the welfare of the animal if it was mismanaged. Cattle are 
grazing animals. If they were deprived of food and forced to stand in the sun it could 
be very detrimental to their welfare. 
To conclude this section, it is more likely that the creation of transgenic animals 
has a greater poteintial for creating welfare problems compared to using products 
derived from technology such as vaccines and hormones. 
ANIMAL PHARMACEUTICAL FACTORIES 
Another use for transgenic animals is producing medically valuable substances 
such as clotting factor for hemophiliacs. These substances would be produced in the 
milk and could be continually harvested via milking. Researchers at the AFRC Institute 
of Animal Physiology in England have produced sheep which produce medically useful 
clotting factor for hemophiliacs and a,-antitrypsin.22 The ability to produce the anti-
clotting factor can be passed on to the offspring. 
This genetic change appears to have no detrimental effect on the animal's 
welfare. Michael Fox admits that "If there is no animal suffering following certain 
genetic changes, then it is difficult to argue against such molecular farming, where 
animals are used as protein factories. " 11 If animals are raised commercially for the 
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production of pharmaceutical substances it is essential that they be housed in an 
environment which provides them adequate stimulation so they do not develop 
stereotypies and other abnormal behavior. These animals should be kept in a dairy herd 
environment where they can socialize with herdmates. Housing in individual barren 
stalls would not be acceptable from a welfare standpoint. Researchers must also be 
careful not to insert genes or substances which may make the animal sick or cause 
chronic health problems. 
MOSAIC ANIMALS 
Genetic material from two different species are combined to form an animal 
which is a genetic mosaic. Sheep and goat genes will produce an odd looking animal 
which has patches of goat tissue and patches of sheep tissue throughout its body. Wool 
grows out of one body area and goat hair out of another. At the present time their is 
no practical use for mosaics. However, they did further understanding of how genes 
work. 
I had the opportunity to see and touch a geep (goat-sheep mosaic) at the 
University of California. The animal was several years old and appeared healthy. It did 
not appear to be suffering in any way. Ethical concerns will be discussed later in this 
paper. 
ADDING AND DELETING GENES 
Husbandry practices such as castration and dehorning have been critisized as 
being detrimental to animal welfare. Biotechnology may provide a way to eliminate 
painful surgery. Some naturally polled (hornless) cattle have undesirable traits 
compared to the horned varieties. With genetic engineering the horn gene may be able 
to be selectively removed without affecting the other desirable traits. 
Male animals can be immunized against luteinizing hormone.23 This results in a 
castration-like response. Present research using conventional methods produces a 
somewhat variable response. Perhaps genetic engineering could be used to produce a 
more effective nonsurgical castration. 
The latest developments in biotechnology enable researchers to specifically 
inactivate specific genes in mice.24 This method will enable scientists to probe the 
purpose of a single gene throughout the life of an animal. This technology will provide 
great knowledge of biology but it may also be very detrimental to small numbers of 
mice. However, it is likely to be less invasive and aversive to the mice than many types 
of research that do not involve biotechnology. This research has tremendous potential 
to improve the welfare of both people and animals by finding cures for genetic disorders. 
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TRANSGENIC ANIMALS AND CLONES IN BIOMEDICAL RESEARCH 
The use of transgenic mice and clones of cells in biomedical research may provide 
medical breakthroughs. Biotechnology is being used to make discoveries that may 
provide a cure for autoimrnune disorders such as diabetes, rheumatoid arthritis, psoriasis 
and multiple sclerosis.25•26•27 Pigs are being used to learn how to direct new genes into 
specific tissues instead of allowing them to express themselves all over the body.27 This 
could lead to treatments for clogged arteries and cancer. The new genes would only be 
active at specific sites. AIDS is another disease where biotechnology is being used to 
research treatments. Biomedical research utilizing transgenic animals and genetic 
engineering is absolutely essential to find a cure or a vaccine for many serious human 
and animal diseases. However, the use of biotechnology to make farm animals more 
productive is much less important to society than finding cures for serious human and 
animal diseases. Michael Fox (1989) states "We should ask why we need to genetically 
engineer farm animals, especially in these times of agricultural surpluses and chronic 
over production." 13 The number of animals which may have their welfare compromised 
in biomedical research is a tiny fraction of the numbers of animals used for food. 
Biomedical and basic research must never be confused with product testing of cosmetics 
and other substances on animals. Many product testing uses of animals could be 
replaced with tissue cultures and other substitutes. Some of these nonanimal alternatives 
are the products of biotechnology research. This is another example of how 
biotechnology can improve animal welfare. 
Previously, the statement was made that farm animals, with increased disease 
resistance, may be a threat to wildlife habitats. On the other hand, biotechnology and 
cloning can be used to preserve wildlife. Rare wildlife can be cloned and gestated by 
common domestic animals. 
INDIRECT USES 
Products developed using the tools of biotechnology can also be used as 
diagnostic tests for diseases or for identification. Branding with hot irons is used as a 
method of identifying cattle in the United States and other countries. If inexpensive 
DNA fingerprinting tests could be developed for cattle, stolen animals and their meat 
could be easily traced. This could eliminate painful branding. Recent research reported 
at the American Society of Animal Science meetings in 1990 indicate that DNA 
fingerprinting of livestock may be feasible.28•29 DNA fingerprinting could also be used 
to assist law enforcement officials on determining the origin of products made from 
poached wildlife. 
Biotechnology can also be used to develop faster and more accurate diagnostic 
tests for animal diseases. Swine dysentary causes severe diarrhea in piglets. Eradication 
of the disease is difficult because present tests cannot detect carriers which can spread 
the disease even though they do not show symptoms. A new DNA probe test can now 
detect carriers and eradication of this disease may now be possible.30 
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ETHICAL CONSIDERATIONS 
Some scientists have stated that changing animals with genetic engineering is no 
different than changing animals with selective breeding. Indiscriminate over selection 
for single traits in dogs and farm animals has caused many health problems such as hip 
dysplasia and an extremely nervous temperament in lean fast growing pigs. These pigs 
are excitable and are very difficult to handle humanely in a high speed slaughter plant. 
It is a problem pork producers must address before a serious animal welfare problem 
is created.31 Maybe temperament genes could be disassociated from productivity traits. 
Michael Fox, Humane Society of the U.S. argues that biotechnology cannot be compared 
to selective breeding because genetic engineering makes it possible to cross species 
boundries and greatly accelerate genetic change.U 
The editor of Science also agrees that the use of recombinant DNA greatly 
accelerates change.32 He writes further "we must proceed cautiously in introducing new 
genes and new combinations of genes into species, long-term experiments are needed 
to study detrimental effects. We are no where near the knowledge needed to genetically 
engineer the complex behavior of a wolf or dog." 32 An original wolf might say to a dog, 
you have lost your freedom. Your obsequiousness is humiliating to the family Canida." 
The dog could reply "I am less warlike, far more altruistic and besides its a wonderful 
standard of living. " 32 Whether society prefers to have wolves or dogs remains to be 
seen.32 
There is a point where science and intellectual logic cannot provide all the 
answers to the ethics of manipulating genes. Ethical decisions are often a matter of 
personal convictions. Bernard Rollin emphasizes that emotion is a necessary component 
of morality.33 There needs to be a balance between strictly emotional and strictly 
intellectual avenues of making ethical decisions. 
For the last fifteen years I have worked on methods to improve the welfare of 
farm animals during handling, transport and slaughter. Below I will present my feelings. 
When I visited a research lab and petted the GEEP (goat-sheep mosaic) I did not feel 
repulsed. Even though it looked funny it acted like a normal tame animal. It did not 
appear to be afflicted with any of problems which occur in pigs with human growth 
genes. It also appeared to be neurologically normal and did not show any signs of 
excitability or depression. I am repulsed by animals that have been grossly distorted to 
the point where they have physical problems such as bull dogs and Pietrain pigs. I found 
a quivering Pietrain boar at a French livestock show pathetic. 
There is great concern that livestock housed in intensive farming systems suffer 
due to boredom and a lack of stimulation. It has been suggested that animals could be 
genetically changed to adapt them to even more intensive housing. Would it be ethical 
to create microcephalic farm animals with reduced brain capacity which would not 
suffer? I find this idea repulsive. One reason I find the idea of microcephalic animals 
repellent is because I like to interact with animals. I don • t want to see them turned into 
machines. That would be moving backward instead of evolving forward. Some scientists 
may dismiss my remarks as mere emotion, but feelings do have a place in making ethical 
decisions. People that are involved in an activity day after day can become numb to its 
ethical implications. On the other hand, people which have had no meaningful contact 
and are too detached and unknowledgable will also be unable to make sound ethical 
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decisions. I have observed workers in slaughter plants abusing animals because they 
become "numb." 34 Managers in a distant corporate office in a far away city are too 
detached to care. Slaughter plants that maintain high standards of human treatment 
have a person who acts as the "plant conscience." This person is usually an upper 
manager who has enough involvement to avoid detachment but does not participate to 
the point where he becomes numb. Biotechnology laboratories also need a person to 
be the "lab conscience." This person needs to be well informed scientifically but also 
be somewhat of an outsider so he can question. 
Extreme philosophical positions against biotechnology are often made by people 
who have little technical knowledge or no direct contact with an ill person who could 
directly benefit from genetic engineering research. It is very likely, that an ardent animal 
rights activist would soften his stance against biotechnology after he discovered that his 
own child had hemophilia or diabetes. Two diseases whose victims can benefit from 
biotechnology research. I have asked several animal rights activists if they would use 
products derived from animal research on an ill child. Often I got no answer and the 
question was evaded. 
Bernard Rollin discusses moral shifts in his book on Animal Rights and Human 
Morality. Moral shifting involves feelings. If you visited and interacted with a sick child 
your moral position may shift towards supporting biotechnology. If you observed an 
animal tortured by a callous unethical researcher your stance may shift against 
biotechnology. 
Extreme positions which justify absolute freedom of inquiry and that the end 
always justifies the means are often made by people who have knowledge in one small 
area and a narrow range of experiences. The become ethically blind. This is why 
courses in literature, history, ethics and philosophy should be part of a scientist 1 s and 
business person 1 s training. I have observed scientists who softened their stance against 
animal welfare after they learned more about ethology and animal behavior. They no 
longer viewed the animals as physiological machines. 
Decisions on the ethical use of biotechnology need to be made by a group of well 
informed individuals. I also believe in the concept of ethical cost. A researcher would 
have greater justification to perform an invasive or painful procedure to find a cure for 
AIDS compared to finding a substance to make pigs grow a little faster. A cure for 
AIDS has a higher ethical priority than the profit motive of a new growth promoter. 
Causing animals to suffer to make them grow a little faster would not be ethically 
justified especially in this era of agricultural surpluses. 
SYMBIOSIS 
Last year I read an article that had a profound effect on my thinking. The article 
was titled The Ancient Contract and it presented a natural-historical view of our evolving 
relationship with animals.35 This view presents a middle ground between animal rightists 
which make the moral status of animals equal to humans and the Cartesian view that 
treats animals as machines with no feelings. 28 
This is when I really started to think about the biological concept of symbiosis. 
A symbiotic relationship is mutually beneficial to both organisms. It is not parasitism. 
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There are many examples of symbiotic relationships between different organisms in 
nature. We feed and protect animals from predators. Domestic animals are slaughtered 
at an early age but they do not suffer the pain of being ripped apart alive by a predator 
or starving from lack of food. To maintain symbiosis we must treat animals humanely 
and give them a good life. Housing systems that cause sensory restriction symptoms or 
abnormal stereotypies would not be acceptable.36 Andrew Rowan at Tufts University 
states, "In many circumstances the animal rights movement over romanticizes nature. "35 
On the other hand we must respect animals as sentient beings and that our relationship 
must be truly symbiotic. To me it is equally repulsive and unethical to use either 
biotechnology or old-fashioned crossbreeding to create animals that have physical or 
neurological disabilities. The animal should still be an animal even if it photosynthsizes 
sunlight. Nervous excitable pigs or microcephalic dairy cows cannot be handled like 
normal animals. They would have to be put in boxes and treated more like objects. 
Treating animals with a complex brain as objects is totally wrong. Some of the 
genetically excitable lines of nervous hybrid pigs cannot be handled humanely in 
conventional race systems used in slaughter plants. The animals pile up and refuse to 
walk up the race. Pigs with a calm temperament can be easily handled in these systems. 
SANCTI1Y OF LIFE 
One view is that recombinant DNA techniques violates the sanctity and dignity 
of life.36 I agree with the editor of Science who says we must proceed cautiously but I 
also think it is important to keep moving forward and advance knowledge. If we stop 
evolving we will stagnate as a species. 
There are some important lessons to learn from history. Medical developments 
throughout history have been delayed for centuries due to religious taboos about 
violating the sanctity of the human body. The ancient Greek physician Galen made 
erroneous conclusions about human anatomy by studying pig anatomy. Over a thousand 
years elapsed until Andreas Vesalius dared conduct an accurate human dissection in 
1543.37 Another doctor named Servatus was less cautious in publishing his results and 
he was burned at the stake for heresy.37 After this time the knowledge of medicine 
proceeded more rapidly. Throughout history there have been other examples of 
forbidden knowledge. Giordano Bruno who lived at the same time as Vesalius was also 
burned at the stake because he provided the first concept of an infinite universe.38 
I design equipment for slaughtering animals and I often have many thoughts 
about the relationship between humans and other forms of life. I got in this business 
because I wanted to reduce suffering. Equipment that reduces suffering that I developed 
is now being installed in major beef slaughter plants. Hunting and agriculture were the 
first science and technology. I have no desire to give up science and technology on the 
other hand we must become much more sensitive to ethical and environmental concerns. 
Science, engineering and the use of our intellect is an important part of being human, 
but morality is also essential. I have experienced moral shifts due to experience. Ten 
years ago I sometimes questioned whether people should use animals for food. Today 
I feel that humans can use animals for food and research in an ethical manner. First of 
all we must practice symbiosis with the animals and make our relationship with them 
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mutually beneficial to both. We must never view animals as machines that we can just 
use. Treating animals as things would violate the sanctity of life. Over the years I have 
used my engineering skills to improve slaughtering systems. When the new systems are 
supervised by ethical managers the cattle experience no pain and almost no fear or 
excitement. Recently I had the opportunity to drive the cattle into the newest state of 
the art system. I felt good about it because there was no fear or suffering. As a result 
of this experience my position on the quality of animal housing systems is hardening. 
Some of the housing systems for pigs provide a poor quality of life. People that abuse 
animals should be punished. 
Sometimes I have thought, "Maybe someday biotechnology will make the 
slaughter plant obsolete." If this happens, there will be much greater ethical questions 
than killing animals for food. Humans will be the first species who could control their 
own evolution. With biotechnology, plants could be changed to grow protein with all the 
essential amino acids. Maybe meat could be grown on the vine as "beef steak 
tomatoes." I do not find this idea repulsive because a block of muscle would have no 
brain or nervous system. 
The process of sequencing genes is slow, but new developments such as the 
scanning probe microscope may greatly accelerate sequencing of both the human and 
animal genomes. Maybe the genetic sequence of many kinds of animals could be stored 
in a super computer and food shortages could be eliminated by inserting the genes for 
photosynthesis into people. We would no longer have to grow plants or animals for 
food . 
Maybe aggressive warlike behaviors could be controlled by making genetic 
changes in our brains. Maybe biotechnology can help save us from third world dictators 
blowing up the world with the atomic bomb. If an atomic war breaks out all people, 
animals and the environment will suffer greatly. Sequencing the humane genome may 
unlock many secrets such as: why do people have such a large cerebral cortex and the 
chimpanzee has a smaller brain even though both species have 98% of the same genes? 
Why do pigs have a genome similar to humans except that the chromosome pieces are 
in a different order?40 There are possibilities of expanding both human and animal 
intelligence. It may be only a matter of changing a few regulator genes to delay maturity 
of the brain and allow it to further develop (Jaak Panksepp, Bowling Green State 
University, 1989). Probing into these great mysteries will create serious ethical 
questions. What knowledge should be forbidden or allowed? 
The huge mega science projects of the 1990 1 s such as sequencing the human 
genome,33 the Hubble Space Telescope and the super collider replace the pyramid and 
cathedral building of our ancesters. There is a basic human drive to figure out who and 
what we are. One of the main purposes of the Hubble Space telescope is to see all the 
way to the beginning of the universe. Years ago, scientists were burned at the stake for 
talking and writing about these ideas. There are no simple answers to ethical questions. 
History tells us, that yesterday 1 s heresy is accepted science of today. 
I take a middle road approach of advancing biotechnology carefully. Humans as 
a species will stagnate if we don 1 t keep progressing. We certainly do not want to plunge 
into a terrible time like the dark middle ages of Europe. Using our intellect and 
advancing our knowledge is an important human trait. 
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"It is true that free inquiry is integral to our humanity, but so too is morality. So 
the quest for knowledge must be tempered with moral concern. "33 A total lack of moral 
concern can lead to atrocities such as the Nazi medical experiments. We must avoid 
intellectual stagnation which retarded the hisory of medical knowledge but on the other 
hand be moral. Vesalius was a pioneer in cutting through superstition but he was also 
callous. In some of his anatomy experiments he tied down living animals and cut them 
open. Vesalius 's greatest contributions were his anatomy studies which were conducted 
on dead humans. Vesalius went to an extreme when he started torturing live animals. 
Again there needs to be a balance between compassion and the quest for knowledge. 
I will summarize once again, we should proceed cautiously but we should 
definitely proceed. Biotechnology can be used for noble, frivolous or evil purposes. 
Decisions on the ethical use of this powerful new knowledge should not be made by 
extremists or people purely motivated by profit. 
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